Elite 50% OFF Act now – get top investing tools Register Now!

Acumen Pharmaceuticals, Inc.

Contributing Author

Recent Articles by Acumen Pharmaceuticals, Inc.

Nov-18	Acumen Pharmaceuticals to Present on Recruitment Strategies for Phase 2 ALTITUDE-AD Trial and Enhanced Brain Delivery Technology at 18th Annual Clinical Trials on Alzheimer's Disease (CTAD) Conference ABOS GlobeNewswire
Nov-17	Acumen Pharmaceuticals Announces First Participant Dosed in Phase 2 Open-Label Extension Study of Sabirnetug in People with Early Alzheimer's Disease ABOS GlobeNewswire
Nov-12	Acumen Pharmaceuticals Reports Third Quarter 2025 Financial Results and Business Highlights ABOS GlobeNewswire
Nov-10	Acumen Pharmaceuticals Appoints George Golumbeski, Ph.D., as Chairman of its Board of Directors ABOS GlobeNewswire
Nov-05	Acumen Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 12, 2025 ABOS GlobeNewswire
Nov-04	Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference ABOS GlobeNewswire
Aug-26	Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences ABOS GlobeNewswire
Aug-12	Acumen Pharmaceuticals Reports Second Quarter 2025 Financial Results and Business Highlights ABOS GlobeNewswire
Aug-05	Acumen Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 12, 2025 ABOS GlobeNewswire
Jul-28	Acumen Pharmaceuticals Presents Studies Showing the Utility of a pTau217 Assay in Screening for a Phase 2 Alzheimer's Disease Trial and Validates Sabirnetug Oligomer-Selectivity, at the Alzheimer's Association International Conference (AAIC) 2025 ABOS GlobeNewswire
Jul-15	Acumen Pharmaceuticals and JCR Pharmaceuticals Enter Strategic Collaboration, Option and License Agreement to Develop Enhanced Brain Delivery Therapy for Alzheimer's Disease ABOS GlobeNewswire
Jul-10	Acumen Pharmaceuticals to Present Studies on Cost Savings Associated with Use of pTau217 Screening Assay in Phase 2 ALTITUDE-AD Study and Sabirnetug Oligomer-Selectivity at the Alzheimer's Association International Conference (AAIC) 2025 ABOS GlobeNewswire
May-13	Acumen Pharmaceuticals Reports First Quarter 2025 Financial Results and Business Highlights ABOS GlobeNewswire
May-07	Acumen Pharmaceuticals to Participate in the Bank of America Healthcare Conference ABOS GlobeNewswire
May-06	Acumen Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025 ABOS GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.